DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Kumar S, Kaufman JL, Gasparetto C. et al.
Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma.
Blood 2017;
130: 2401-2409
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.